HERA

Nov 27 2024HEALTH

Epilepsy Treatments: A Nationwide Look at Laser and Nerve Stimulation

Let's take a look at how two different treatments for epilepsy have been used across the United States. We're talking about Laser interstitial thermal therapy (LITT) and Vagus Nerve stimulation (VNS). Both are used to help people with epilepsy that doesn't respond to medicine. First, it's important

reading time less than a minute
Nov 27 2024SCIENCE

Solving Cancer's Puzzle: How PROTACs Are Redefining Therapies

Have you ever heard of a tiny molecule that can trick cells into getting rid of bad proteins? Meet PROTACs, a fascinating concept in biotherapeutics. PROTAC stands for Proteolysis Targeting Chimeras. These clever molecules are designed to lure specific proteins and escort them to the cell's waste di

reading time less than a minute
Nov 27 2024HEALTH

Health Workers' Knowledge and Care for Tropical Diseases in Guinea

Ever wondered how healthcare providers in Guinea handled certain tropical diseases? A recent study looked into this, focusing on diseases like trachoma and onchocerciasis. From November 7th to 22nd, 2022, researchers surveyed 86 healthcare providers in the Forecariah health district. They used a que

reading time less than a minute
Nov 27 2024HEALTH

Gene Therapy in Blood Diseases: Milestones and Challenges

Have you ever wondered how gene therapy is changing the way scientists treat blood disorders? Well, the journey started with the discovery of DNA's structure and gene regulation mechanisms in the early 20th century. This foundation laid the groundwork for gene therapy (GT), which uses platforms like

reading time less than a minute
Nov 26 2024HEALTH

How Cancer Treatment Affects Daily Life for Esophageal Cancer Patients

Esophageal cancer (EC) patients undergo significant changes during and after their treatment with chemoradiotherapy. These changes include shifts in body mass index (BMI), performance status, nutrition status, symptom distress, and physical fitness. A recent study explored how these factors evolve o

reading time less than a minute
Nov 26 2024HEALTH

How FH Deficiency Builds Tumor Vulnerabilities

Ever wondered how certain tumors become resistant to treatments? Well, let's dive into the fascinating world of FH deficiency and chromatin helicase CHD6. When a protein called FH is missing or not working right, it leads to a specific type of renal cell carcinoma (RCC). This kind of cancer doesn't

reading time less than a minute
Nov 26 2024HEALTH

Psychedelics and Pot: A New Look at Addiction

Did you know that cannabis use disorder, or CUD, is a growing concern in the United States? With millions of people affected, the search is on for effective treatments. Recently, some intriguing research has surfaced, focusing on psychedelic compounds. No, not the ones that make you trip in a bad wa

reading time less than a minute
Nov 25 2024HEALTH

Predicting Peptide Power: A New Way to Find Drug Candidates

Ever wondered why some tiny peptides can pack a big punch when it comes to treating diseases? These little protein chunks could be the next big thing in medicine. But finding the right ones isn't easy. Scientists have a tough time predicting how peptides will interact with proteins in our bodies. Th

reading time less than a minute
Nov 25 2024HEALTH

How Nurses in Poland Approach Subcutaneous Immunoglobulin Therapy for Primary Antibody Deficiency

Primary antibody deficiency (PAD) is a condition where the body struggles to fight infections. One effective treatment is subcutaneous immunoglobulin replacement therapy (scIgRT), which patients can administer at home. This method has its pros and cons, and nurses play a crucial role in making it wo

reading time less than a minute
Nov 25 2024HEALTH

New Hope for BTC Patients: The Durvalumab + Chemo Combination in Action

Biliary tract cancer (BTC), a tough cancer that starts in the bile ducts or gallbladder, has been a serious challenge due to its poor outlook. A big trial called TOPAZ-1 showed that adding durvalumab to the standard first-line chemo (gemcitabine and cisplatin) helped patients live longer than chemo

reading time less than a minute